Comparative study of the cellular pharmacodynamics of calcineurin inhibitors between patients with chronic renal failure awaiting renal transplantation and cirrhosis patients awaiting liver transplantation

Cell Transplantation

Volumn 18, Issue 5-6, 2009, Pages 639-646

  Kihara, Yu ^a   Matsuno, Naoto ^a   Mijiti, Abuduxukuer ^a   Nagao, Takeshi ^a   Takeuchi, Hironori ^b   Unezaki, Sakae ^b   Hirano, Toshihiko ^b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Calcineurin inhibitors; Chronic renal failure; Cirrhosis; Liver transplantation; Peripheral blood mononuclear cells; Renal transplantation

Indexed keywords

CALCINEURIN; CONCANAVALIN A; CYCLOSPORIN A; TACROLIMUS;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; IMMUNOMODULATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 70349251235     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1177/096368970901805-620     Document Type: Article

References (31)

1. Aoki, C. A.; Roifman, C. M.; Lian, Z. X.; Bowlus, C. L.; Norman, G. L.; Shoenfeld, Y.; Mackay, I. R.; Gershwin, M. E. IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. J. Autoimmun. 27:50-53; 2006.
2. Bardet, V.; Junior, A. P.; Coste, J.; Lecoq-Lafon, C.; Chouzenoux, S.; Bernard, D.; Soubrane, O.; Lacombe, C.; Calmus, Y.; Conti, F. Impaired erythropoietin production in liver transplant recipients: The role of calcineurin inhibitors. Liver Transpl. 12:1649-1654; 2006. (Pubitemid 44742544)
3. Berenquer, M.; Aquilera, V.; Prieto, M.; San Juan, F.; Rayon, J. M.; Berenquer, J. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients. Liver Transpl. 12:762-767; 2006.
4. Bock, H. A. Steroid-resistant kidney transplant rejection: Diagnosis and treatment. J. Am. Soc. Nephrol. 12:S48-S52; 2001.
5. Braun, W. E. Renal transplantation: Basic concepts and evolution of therapy. J. Clin. Apheresis 18:141-152; 2003.
6. Dudley, J.; Truman, C.; McGraw, M.; Tizard, J.; Haque, G.; Bradley, B. Estimation of individual sensitivity to cyclosporin in children awaiting renal transplantation. Nephrol. Dial. Transplant. 18:403-410; 2003.
7. Fiuza, C.; Salcedo, M.; Clemente, G.; Tellado, J. M. In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J. Infect. Dis. 182:526-533; 2000.
8. Haczku, A.; Alexander, A.; Brown, P.; Assoufi, B.; Li, B.; Kay, A. B.; Corrigan, C. The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: Comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma. J. Allergy Clin. Immunol. 93:510-519; 1994.
9. Hasenbein, W.; Albani, J.; Englert, C.; Spehr, A.; Grabhorn, E.; Kemper, M. J.; Burdelski, M.; Ganschow, R. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation. Pediatr. Transplant. 10:938-942; 2006.
10. Haycock, K. A.; Roth, R.; Gagnon, J. Statview. Berkeley, CA: Abacus Concepts; 1994.
11. Hearing, S. D.; Norman, M.; Probert, C. S.; Haslam, N.; Dayan, C. M. Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes. Gut 45: 382-388; 1999.
12. Hilgard, P.; Kahraman, A.; Lehmann, N.; Seltmann, C.; Beckebaum, S.; Ross, R. S.; Ross, R. S.; Baba, H. A.; Malago, M.; Broelsch, C. E.; Gerken, G. Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: Effects on virus replication and recurrent hepatitis. World J. Gastroenterol. 12:697-702; 2006.
13. Hirano, T. Cellular pharmacodynamics of immunosuppressive drugs for individualized medicine. Int. Immunopharmacol. 7:3-22; 2007.
14. Hirano, T.; Akashi, T.; Keira, T.; Oka, K.; Ihoya, N.; Yoshida, M. Clinical impact of cyclosporine cellular-pharmacodynamics in minimal change nephrotic syndrome. Clin. Pharmacol. Ther. 68:532-554; 2000.
15. Hirano, T.; Oka, K.; Takeuchi, H.; Kozaki, K.; Matsuno, N.; Nagao, T.; Kozaki, M.; Ichikawa, M.; Yoshida, M.; Umezawa, Y.; Hirata, M.; Oh-I, T.; Koga, M. Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis and psoriasis: Possible implications for individual therapeutic efficacy. Clin. Pharmacol. Ther. 62:652-664; 1997.
16. Hirano, T.; Oka, K.; Takeuchi, H.; Sakurai, E.; Matsuno, N.; Tamaki, T.; Kozaki, M. Clinical significance of glucocorticoid pharmacodynamics assessed by anti-lymphocyte action in kidney transplantation: Marked difference between prednisolone and methylprednisolone. Transplantation 57:1341-1348; 1994. (Pubitemid 24145580)
17. Hirano, T.; Oka, K.; Umezawa, Y.; Hirata, M.; Oh-i, T.; Koga, M. Individual pharmacodynamics assessed by antilymphocyte action predicts clinical cyclosporine-efficacy in psoriasis. Clin. Pharmacol. Ther. 63:465-470; 1998.
18. Kirkham, B. W.; Corkill, M. M.; Davison, S. C.; Panayi, G. S. Response to glucocorticoid treatment in rheumatoid arthritis: In vitro cell mediated immune assay predicts in vivo responses. J. Rheumatol. 18:821-825; 1991.
19. Lakey, J. R.; Kin, T.; Warnock, G. L.; Shapiro, A. M.; Tsapogas, P.; Imes, S.; Korbutt, G. S.; Kneteman, N. M.; Rajotte, R. V.; Ryan, E. A. Long-term graft function after allogeneic islet transplantation. Cell Transplant. 16:441-446; 2007.
20. Levy, G.; Grazi, G. L.; Sanjuan, F.; Wu, Y.; Muhlbacher, F.; Samuel, D.; Friman, S.; Jones, R.; Cantisani, G.; Villamil, F.; Cillo, U.; Clavien, P. A.; Klintmalm, G.; Otto, G.; Pollard, S.; McCormick, P. A. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. Liver Transpl. 12:1464-1472; 2006.
21. McCormack, P. L.; Keating, G. M. Tacrolimus: In heart transplant recipients. Drugs 66:2269-2279; 2006.
22. Mijiti, A.; Matsuno, N.; Iwahori, T.; Takeuchi, H.; Nagao, T.; Oka, K.; Hirano, T. Increased sensitivities of peripheral blood mononuclear cells to immunosuppressive drugs in cirrhosis patients awaiting liver transplantation. Cell Transplant. 15:885-891; 2006. (Pubitemid 46174538)
23. O'Grady, J. G.; Hardy, P.; Burroughs, A. K.; Elbourne, D.; UK and Ireland Liver Transplant Study Group. Randomized controlled trial of tacrolimus versus microemulsified cyclosporin (TMC) in liver transplantation: Poststudy surveillance to 3 years. Am. J. Transplant. 7:137-141; 2007.
24. Ono, Y.; Watanabe, T.; Matsumoto, K.; Ito, T.; Kunii, O.; Goldstein, E. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood. J. Infect. Chemother. 10:200-207; 2004.
25. Plosker, G. L.; Foster, R. H. Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59:324-389; 2000.
26. Ponte, G. M.; Baidal, D. A.; Romanelli, P.; Faradji, R. N.; Poggioli, R.; Cure, P.; Froud, T.; Selvaggi, G.; Pileggi, A.; Ricordi, C.; Alejandro, R. Resolution of severe atopic dermatitis after tacrolimus withdrawal. Cell Transplant. 16:23-30; 2007. (Pubitemid 46516655)
27. Reichenspurner, H. Overview of tacrolimus-based immunosuppression after heart or lung transplantation. J. Heart Lung Transplant. 24:119-130; 2005. (Pubitemid 40215585)
28. Shinkura, N.; Ikai, I.; Egawa, H.; Yamauchi, A.; Kawai, Y.; Inomata, Y.; Inamoto, T.; Tanaka, K.; Yamaoka, Y. Presence of anti-FKBP12 autoantibodies in patients with liver allografts: Its association with allograft rejection. Transplantation 64:1336-1342; 1997. (Pubitemid 27495969)
29. Shinkura, N.; Ikai, I.; Yamauchi, A.; Hirose, T.; Kawai, Y.; Inamoto, T.; Ozaki, S.; Iwai, M.; Bona, C.; Yamaoka, Y. Autoantibodies to FK506 binding protein 12 (FKBP12) in autoimmune diseases. Autoimmunity 29:159-170; 1999. (Pubitemid 29204302)
30. Takeuchi, H.; Hirano, T.; Oka, K.; Mizumoto, K.; Akashi, T.; Uchiyama, M.; Degawa, T.; Kozaki, K.; Matsuno, N.; Nagao, T.; Kozaki, M.; Sakurai, E. Lymphocyte-sensitivities to cyclosporine and tacrolimus in chronic renal failure patients and their significance on renal transplantation. Transplant. Proc. 30:36-39; 1998.
31. Tanabe, K. Calcineurin inhibitors in renal transplantation: What is the best option? Drugs 63:1535-1548; 2003.